|
 |
NelfinavirThis page contains recent news articles, when available, and an overview of Nelfinavir but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Nelfinavir (when available) Nelfinavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Nelfinavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. For the treatment of HIV infection. Mechanism Of Action: Nelfinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. News Articles on Nelfinavir SEXUALLY TRANSMITTED DISEASES:- THEIR NATURE AND CURE - THIRD PUBLICATION - Dec 18, 2009 Didanosine, Efavirenz, Lamivudine, Stavudine, Indinavir, Nelfinavir, Abalavir. Eminence Consult Natural Medicine destroys HIV and cures AIDS. ... Modern Ghana Coalescing purpuric plaques - Nov 10, 2009 His medications included Combivir (lamivudine/zidovudine) and nelfinavir. A biopsy revealed increased spindle cells with vascular slits. ... Clinical Advisor Market Watch - Nov 5, 2009 ...ketoconazole, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, or telithromycin). ... The Hospitalist Online New drug for type 2 diabetes - Oct 29, 2009 Interactions: Potentiated by strong CYP3A4/5 inhibitors (eg, ketoconazole, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ... Clinical Advisor How antiretroviral therapy prolongs life - Oct 21, 2009 ...ritonavir and nelfinavir prevent the cutting of the precursor polypeptide that is processed into smaller core proteins. l Entry inhibitors: these drugs ... The Southern Times AIDS Drugs May Help Against Cancer, Too - Sep 18, 2007 Nelfinavir was also found to be effective against breast cancer cells that are resistant to ... The scientists also tested nelfinavir in mice that had been ... New York Times HIV Drug Might Fight Cancer - Sep 1, 2007 Based on this new finding, the HIV protease inhibitor nelfinavir is being ... The researchers hit upon the idea of testing nelfinavir and other protease ... Washington Post Nelfinavir (Viracept) recalled in UK and Europe following contaminatio... - Jun 6, 2007 Drug company, Roche, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMEA) issued alerts tonight ... Aidsmap Nelfinavir and nevirapine well tolerated during pregnancy - May 9, 2005 HAART regimens containing either the protease inhibitor nelfinavir or the NNRTI nevirapine are well tolerated during pregnancy, according to a Dutch study ... Aidsmap Warning Issued on Nelfinavir (Viracept) for Children and Pregnant … - Sep 10, 2007 By Michael Smith, Senior Staff Writer, MedPage Today. NEW YORK, Sept. 10 -- In the wake of a recall in Europe of nelfinavir (Viracept) because of a ... MedPage Today Learn about Nelfinavir from Consumer Reports Health. - Jan 1, 2008 Nelfinavir is used in combination with other medications to treat human immunodeficiency virus (HIV) infection in patients with or without acquired ... consumerreports.org … and Pharmacodynamics of Efavirenz and Nelfinavir in HIV-infected … - Mar 27, 2007 Efavirenz and nelfinavir doses were adjusted to achieve AUC values of ... Efavirenz and nelfinavir oral clearance increased 37 and 62% from weeks 2 to 56, ... Nature.com Nelfinavir (Systemic).(Drug overview) - Aug 1, 2006 Nelfinavir ( nel-FIN-a-veer) is used, usually in combination with other medicines, in the treatment of the infection caused by the human immunodeficiency ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Nelfinavir (Systemic). - Feb 1, 2006 Nelfinavir ( nel-FIN-a-veer) is used, usually in combination with other medicines, in the treatment of the infection caused by the human immunodeficiency ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Nelfinavir Acts in HIV-Infected Neonates as in Adults, But Individual... - Feb 7, 2008 By Maria Bishop. BOSTON, MA -- February 7, 2008 -- Adequate exposure to nelfinavir is undetermined for neonates diagnosed with HIV in the first 2 weeks of ... DG News AIDS drug shows potential as weapon against cancer - Aug 31, 2007 The most effective of the drugs was nelfinavir, sold by Roche Holding AG (ROG.VX) as Viracept, the researchers said. The drug also slowed the growth of both ... Reuters HIV/AIDS Therapy; Nelfinavir induces adipocyte necrosis by oxidative ... - Mar 20, 2005 ..."Protease inhibitor treatment strongly diminishes mortality in HIV-infected patients. This treatment has also been associated with lipodystrophy and has ... Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones Taking Nelfinavir from Consumer Reports Health. - Jan 1, 2008 Nelfinavir may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:. If high blood sugar is not treated, a serious, ... consumerreports.org Roche says Viracept licence in Europe re-instated - Sep 20, 2007 ..."Roche fully intends to re-supply Viracept (nelfinavir) once the suspension is lifted," the company said. "However, it may take a few months for Viracept to ... Reuters … ; HIV-infected newborns may need higher nelfinavir dose than FDA … - Apr 26, 2006 ..."As a relationship between nelfinavir antiretroviral efficacy and plasma concentrations has been previously established, nelfinavir pharmacokinetics" were ... Pay-Per-View - Immunotherapy Weekly - Factiva, from Dow Jones Drug Safety; Low-dose ritonavir added to nelfinavir regimen is safe... - Nov 29, 2005 2005 NOV 29 - (NewsRx.com) -- Low-dose ritonavir added to a nelfinavir regimen is safe in HIV-infected patients. In a recent report, researchers in Denmark ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones HIV Protease Inhibitor Nelfinavir Being Tested in Cancer - Sep 6, 2007 September 6, 2007 — The human immunodeficiency virus (HIV) protease inhibitor nelfinavir ( Viracept, Pfizer) has shown anticancer activity in cell cultures ... Medscape Nelfinavir Added to Chemotherapy Shows Promise for Pancreatic Cancer - Jun 24, 2008 NEW YORK JUN 24, 2008 (Reuters Health) - A combination of the protease inhibitor nelfinavir and a conventional chemotherapy regimen of gemcitabine and ... Cancerpage.com … ; HIV-infected newborns may need higher nelfinavir dose than FDA … - Apr 24, 2006 ..."As a relationship between nelfinavir antiretroviral efficacy and plasma concentrations has been previously established, nelfinavir pharmacokinetics" were ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones HIV/AIDS Therapy; CYP2C19 converts nelfinavir to a bioactive metabolit... - Feb 18, 2005 However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to nelfinavir hydroxy-t-butylamide (M8), which exhibits potent antiviral ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Kenya: HIV Patients Suffer As Drug is Recalled - Aug 9, 2007 The drug, whose generic name is Nelfinavir, is considered to be an important defence against HIV and is used by patients who don't respond to first-line ... AllAfrica.com HIV/AIDS Therapy; CYP2C19 converts nelfinavir to a bioactive metabolit... - Feb 14, 2005 However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to nelfinavir hydroxy-t-butylamide (M8), which exhibits potent antiviral ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones … ; HIV-infected newborns may need higher nelfinavir dose than FDA … - Apr 28, 2006 ..."As a relationship between nelfinavir antiretroviral efficacy and plasma concentrations has been previously established, nelfinavir pharmacokinetics" were ... Pay-Per-View - Drug Week - Factiva, from Dow Jones HIV/AIDS Therapy; CYP2C19 converts nelfinavir to a bioactive metabolit... - Feb 14, 2005 However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to nelfinavir hydroxy-t-butylamide (M8), which exhibits potent antiviral ... Pay-Per-View - Anti-Infectives Week - Factiva, from Dow Jones DRUG CAPSULE WHAT YOU SHOULD KNOW - Aug 28, 2006 ...or non-prescription/herbal products, particularly aluminum- and magnesium-containing antacids, digoxin, live vaccines, lovastatin, nelfinavir, warfarin. $2.95 - Milwaukee Journal Sentinel - NewsBank HIV/AIDS Therapy; CYP2C19 converts nelfinavir to a bioactive metabolit... - Feb 14, 2005 However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to nelfinavir hydroxy-t-butylamide (M8), which exhibits potent antiviral ... Pay-Per-View - Hematology Week - Factiva, from Dow Jones … to temporary suspension of nelfinavir's (Viracept) European... - Jun 21, 2007 The license for nelfinavir (Viracept) has been temporarily suspended by European drug ... Roche, the manufacturer of nelfinavir announced that following ... Aidsmap HIV/AIDS Therapy; CYP2C19 converts nelfinavir to a bioactive metabolit... - Feb 19, 2005 However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to nelfinavir hydroxy-t-butylamide (M8), which exhibits potent antiviral ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones … Drug Reaction; Step-wise intervention effectively manages nelfinavi... - Jan 2, 2006 Keywords: Toronto, Ontario, Canada, HIV/AIDS, Nelfinavir, Diarrhea, Drug Side Effect, Step-Wise Intervention. This article was prepared by AIDS Weekly ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones HIV/AIDS Therapy; CYP2C19 converts nelfinavir to a bioactive metabolit... - Feb 14, 2005 However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to nelfinavir hydroxy-t-butylamide (M8), which exhibits potent antiviral ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones IAS: Roche admits long-standing low-level contamination of nelfinavir - Jul 26, 2007 Nelfinavir (Viracept) manufacturer, Roche, has admitted that some batches of the now-withdrawn protease inhibitor have been contaminated with unacceptable ... Aidsmap HIV/AIDS Therapy; CYP2C19 converts nelfinavir to a bioactive metabolit... - Feb 20, 2005 However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to nelfinavir hydroxy-t-butylamide (M8), which exhibits potent antiviral ... Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones Recall of Viracept (Nelfinavir) - Jun 8, 2007 Pharmaceutical company Roche is taking responsible action with its voluntary recall of the anti-HIV treatment nelfinavir (Viracept), says government ... scoop.co.nz HIV/AIDS Therapy; CYP2C19 converts nelfinavir to a bioactive metabolit... - Feb 14, 2005 However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to nelfinavir hydroxy-t-butylamide (M8), which exhibits potent antiviral ... Pay-Per-View - Hepatitis Weekly - Factiva, from Dow Jones … University Medical Center; CYP2C19 converts nelfinavir to a... - Feb 16, 2005 However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to nelfinavir hydroxy-t-butylamide (M8), which exhibits potent antiviral ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Near-global nelfinavir (Viracept) recall 'very difficult situation' - Jun 20, 2007 The World Health Organization (WHO), drug companies, drug regulators, NGOs and national governments have been working together to minimise the disruption of ... Aidsmap HIV/AIDS Therapy; Nelfinavir induces adipocyte necrosis by oxidative ... - Mar 14, 2005 ..."Protease inhibitor treatment strongly diminishes mortality in HIV-infected patients. This treatment has also been associated with lipodystrophy and has ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones Nelfinavir (Viracept) recall update - Jun 7, 2007 Roche is recalling all nelfinavir (Viracept) manufactured at its Swiss plant with immediate effect. Patients who are currently taking nelfinavir are advised ... Aidsmap AIDS Drug Recall Hits Poorest Patients - Aug 2, 2007 Viracept (generic name Nelfinavir), a medicine for the control and treatment of AIDS which is manufactured by the Swiss laboratory Roche. ... NPR HIV/AIDS Therapy; Nelfinavir induces adipocyte necrosis by oxidative ... - Mar 18, 2005 ..."Protease inhibitor treatment strongly diminishes mortality in HIV-infected patients. This treatment has also been associated with lipodystrophy and has ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Sida: résultats toxicologiques rassurants pour les patients traités... - Jul 25, 2008 La contamination était intervenue lors de la production de la substance active, le nelfinavir, utilisée pour la fabrication du médicament. ... Le Point Depo-medroxyprogesterone in Women on Antiretroviral Therapy: … - Dec 27, 2006 Minor changes in nelfinavir and nevirapine drug exposure were seen after DMPA, ... Drug exposure (AUC 0–12 h) to nelfinavir was reduced with minimal changes ... Nature.com … /AIDS Therapy; Pharmacokinetic established for nelfinavir and its... - Apr 25, 2005 2005 APR 25 - (NewsRx.com) -- Pharmacokinetics was established for nelfinavir and its active metabolite in HIV-1-infected infants. ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones Studies conclude impurity in Roche's Viracept did not increase... - Jul 24, 2008 The discovery of the EMS impurity in some batches of nelfinavir led to a global recall of this HIV medication in June 2007. Since then, the product has been ... eurekalert.org … /AIDS Therapy; C/EBP alpha reverses anti-adipogenic effects of... - Apr 4, 2005 According to recent research from the United States, "Nelfinavir and other HIV protease ... "We report here that nelfinavir promotes loss of cytoplasmic ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones … ; Higher viral load/lower age correlate to nelfinavir-related L90M... - Feb 18, 2005 ..."To assess prevalence of nelfinavir resistance mutations in children receiving highly active antiretroviral therapy, sequencing of protease gene from plasma ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones … ; Higher viral load/lower age correlate to nelfinavir-related L90M... - Feb 14, 2005 ..."To assess prevalence of nelfinavir resistance mutations in children receiving highly active antiretroviral therapy, sequencing of protease gene from plasma ... Pay-Per-View - Hematology Week - Factiva, from Dow Jones … /AIDS Therapy; Pharmacokinetic established for nelfinavir and its... - Apr 29, 2005 2005 APR 29 - (NewsRx.com) -- Pharmacokinetics was established for nelfinavir and its active metabolite in HIV-1-infected infants. ... Pay-Per-View - Drug Week - Factiva, from Dow Jones … ; Higher viral load/lower age correlate to nelfinavir-related L90M... - Feb 16, 2005 ..."To assess prevalence of nelfinavir resistance mutations in children receiving highly active antiretroviral therapy, sequencing of protease gene from plasma ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones … /AIDS Therapy; C/EBP alpha reverses anti-adipogenic effects of... - Apr 8, 2005 According to recent research from the United States, "Nelfinavir and other HIV protease ... "We report here that nelfinavir promotes loss of cytoplasmic ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones European licence for Roche HIV drug Viracept re-established by … - Oct 19, 2007 Viracept (nelfinavir), a protease inhibitor is supplied by Roche outside the US, Canada and Japan. Viracept was first introduced by Roche in 1999. ... Le fermenteur à bioréaction Press Release: Studies Assessed by European Health Authority … - Jul 24, 2008 The discovery of the EMS impurity in some batches of nelfinavir led to a global recall of this HIV medication in June 2007. Since then, the product has been ... Pay-Per-View - PR Newswire Europe - HighBeam Research … Research; The pharmacokinetics of nelfinavir change in HCV and HIV... - Apr 11, 2005 According to recent research from Italy, "in order to evaluate the potential risk of nelfinavir (NFV) accumulation in human immunodeficiency virus ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones European Licence For Roche HIV Drug Viracept Recommended For Re … - Oct 1, 2007 Roche fully intends to re supply Viracept (nelfinavir) once the ... Viracept (nelfinavir), a protease inhibitor is supplied by Roche outside the US, ... Medical News Today - Medical News Today (press release) EC Reinstates License for Roche's Viracept - Oct 22, 2007 The timing of Viracept's (nelfinavir) reintroduction will vary in each country. It is likely to be a few months before the drug is available fully, ... FDA news - FDA news (subscription) Governo pede que pessoas não deixem de tomar Nelfinavir - Jun 8, 2007 BRASÃ?LIA - Enquanto providencia a substituição do remédio do coquetel antiaids Nelfinavir, que está sendo recolhido mundialmente pelo Laboratório Roche por ... O Globo HCV/HIV coinfection guidelines may lead to unnecessarily premature … - Sep 26, 2005 In contrast, participants on nelfinavir had mean 23.3% increases of HCV viral ... In fact, five of eleven nelfinavir-treated coinfected patients with CD4 ... Aidsmap HIV Protease Inhibitors Show Potential As Cancer Treatments - Sep 8, 2007 In this study, nelfinavir and saquinavir were more potent than the other HIV ... Nelfinavir was the most effective of all the protease inhibitors tested, ... emaxhealth.com Vervuilde nelfinavir was niet kankerverwekkend - Sep 2, 2008 De vervuilde nelfinavir die vorig jaar van de markt is gehaald, blijkt niet kankerverwekkend geweest te zijn. Dat blijkt uit een verklaring van het ... Hiv Vereniging Nederland HIV/AIDS Therapy; Researchers' work adds to HIV/AIDS therapy body of ... - Apr 4, 2005 Study 1: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Hepatitis Weekly - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers provide details of new studies and … - Apr 18, 2005 Study 2: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Diabetes Week - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers provide details of new studies and … - Apr 18, 2005 Study 2: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers provide details of new studies and … - Apr 23, 2005 Study 2: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers' work adds to HIV/AIDS therapy body of ... - Apr 4, 2005 Study 1: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers provide details of new studies and … - Apr 18, 2005 Study 2: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Obesity & Diabetes Week - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers' work adds to HIV/AIDS therapy body of ... - Apr 7, 2005 Study 1: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Blood Weekly - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers provide details of new studies and … - Apr 18, 2005 Study 2: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Proteomics Weekly - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers provide details of new studies and … - Apr 20, 2005 Study 2: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Immunotherapy Weekly - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers' work adds to HIV/AIDS therapy body of ... - Apr 10, 2005 Study 1: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers provide details of new studies and … - Apr 18, 2005 Study 2: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers provide details of new studies and … - Apr 24, 2005 Study 2: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones Hackensack University Medical Center; Researchers' work adds to HIV/ … - Apr 6, 2005 Study 1: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones HIV/AIDS Therapy; Researchers' work adds to HIV/AIDS therapy body of ... - Apr 4, 2005 Study 1: CYP2C19 converts nelfinavir to a bioactive metabolite. ... However, the protease inhibitor nelfinavir (Viracept) is metabolized mainly to ... Pay-Per-View - Anti-Infectives Week - Factiva, from Dow Jones Nelfinavir is weer verkrijgbaar - Jul 1, 2008 De proteaseremmer nelfinavir is weer verkrijgbaar. Vorig jaar juli werd er een vervuiling in sommige productiebatches van nelfinavir gevonden, waardoor het ... Hiv Vereniging Nederland Article: Recall of HIV drug leaves poor with little choiceSubstitutes... - Jul 23, 2007 Batches of Roche's HIV protease inhibitor Viracept (nelfinavir) are being ... Viracept (nelfinavir), a leading PI is supplied by Roche outside the US and ... Pay-Per-View - International Herald Tribune - HighBeam Research Retiran del mercado mexicano el antirretroviral Nelfinavir - Jun 12, 2007 Laboratorios Roche anunció ayer su decisión de retirar del mercado mexicano el medicamento Nelfinavir, de nombre comercial Viracept, debido a que en algunos ... La Jornada - La Jornada (México) Remise à disposition de Viracept® (nelfinavir) pour le traitement de... - Oct 28, 2008 Depuis le 19 octobre, l'antiprotéase Viracept® (nelfinavir), sous forme de comprimés et de poudre orale, est remis à disposition dans les pharmacies par le ... Femmes et sida Kaletra not associated with raised blood pressure, manufacturer... - Oct 30, 2006 The second was in 155 treatment-naïve people randomised to receive either Kaletra plus zidovudine and lamivudine or nelfinavir plus zidovudine and ... Aidsmap Saúde suspende uso do Nelfinavir no Ceará - Jun 12, 2007 O medicamento Nelfinavir, usado na terapia de pessoas infectadas pelo HIV, foi retirado de circulação no Ceará e demais estados da Federação, ... Diário do Nordeste - Diário do Nordeste (Assinatura) CROI: Saquinavir-based combination prevents mother-to-child HIV … - Feb 22, 2006 One woman switched from ritonavir-boosted saquinavir to nelfinavir after ten days ... This occurred in the nelfinavir group in a woman whose viral load was ... Aidsmap Contamination de Viracept® (nelfinavir) par l'éthylmésylate : pas d' … - Aug 12, 2008 En juin 2007, les Autorités de santé européennes suspendaient temporairement l'autorisation de mise sur le marché de Viracept® (nelfinavir) en raison d'une ... Femmes et sida Long-term complete remission of laryngeal Kaposi's sarcoma after … - Mar 24, 2005 11 The drug combination used in this case followed an institutional protocol: didanosine, an inosine antimetabolite; nelfinavir, an HIV protease inhibitor; ... Nature.com UNIÃO EUROPÉIA SUSPENDE VENDAS DO REMÉDIO ANTI-AIDS … - Aug 7, 2007 O Viracept (mesilato de nelfinavir) também foi recolhido no Brasil em junho, por iniciativa da Roche. A comissão disse que o anúncio baseou-se nas ... G1.com.br Usado no coquetel anti-HIV, Mesilato de Nelfinavir contém impurezas - Jun 8, 2007 Rio - Todos os pacientes que fazem uso do medicamento Mesilato de Nelfinavir (Viracept) contra HIV devem procurar os serviços de saúde onde fazem tratamento ... O Dia Online Descubren un posible cancerÃgeno en un medicamento contra el sida - Sep 11, 2007 El 'Viracept', cuyo nombre genérico es 'nelfinavir', pertenece al grupo de medicamentos contra el sida llamados inhibidores de proteasa que son cruciales en ... La Vanguardia La retirada de uno de los antirretrovirales más usados, un drama en... - Jul 24, 2007 La retirada del mercado de todas las formulaciones del nelfinavir afecta a todo el mundo salvo a Estados Unidos, Canadá y Japón, donde no se habrÃan ... El Diario Montañés 醫管局已è?¯çµ¡ç›¸é—œç—…人å?œæœ?Nelfinavir - Jun 7, 2007 ...醫管局表示， 知悉羅æ°?è—¥å» åœ¨é¦™æ¸¯è‡ªé¡˜å…¨é?¢å›žæ”¶æ‰€æœ‰æ‰¹è™Ÿçš„Nelfinavir 藥物， 已通知 公立醫院å?³æ™‚å?œæ¢ä½¿ç”¨æœ‰é—œè—¥ç‰©ï¼Œ 亦陸續è?¯çµ¡ç?²è™•æ–¹çš„ç´„40 å??專科門診病人å?³æ™‚å?œæ¢ ... 香港電å?° - 香港電å?° Lopinavir/ritonavir not linked to hepatotoxicity regardless of HCV... - Jan 25, 2005 About 75% were male, but there were more women (31%) in the nelfinavir group. Median age was about 37 years. About three-quarters were black and about ... Aidsmap Retrait de lots de Viracept® (nelfinavir) - Jun 6, 2007 L'Afssaps a été informée par les laboratoires Roche d'une contamination par une impureté chimique lors de la production de Viracept® (nelfinavir). ... survivreausida.net Brasil retira medicina contra sida - Jun 8, 2007 Roche informó el miércoles pasado que lotes del medicamento Nelfinavir ... Simao dijo que el Nelfinavir es distribuido actualmente en Brasil a cerca de 9000 ... CNNExpansión.com Pharmazeutische Zeitung online: Nachrichtenarchiv - Apr 11, 2008 Nach dem Rückruf des HIV-Mittels Viracept ® (Nelfinavir) aufgrund von ... Der Proteaseinhibitor Nelfinavir ist ein Virenhemmer der ersten Generation. ... Pharmazeutische Zeitung online HN78 Nelfinavir en atazanavir - Jul 10, 2007 In een oude trial werd atazanavir met nelfinavir vergeleken, gedurende 76 weken. Alle deelnemers kregen daarnaast d4T + 3TC. De deelnemers die nelfinavir ... Hiv Vereniging Nederland Algunas drogas contra el VIH podrÃan ser antitumorales - Sep 6, 2007 Los dos antivirales más potentes en la investigación fueron nelfinavir y saquinavir que lograron, según el estudio, frenar el crecimiento tumoral y acelerar ... Télam Drogas antisida serÃan eficaces contra el cáncer - Sep 7, 2007 Descubrieron asà que tres de las seis drogas -nelfinavir, ritonavir y ... Los dos antivirales más potentes fueron el nelfinavir y el saquinavir: no sólo ... ClarÃn.com Alerta y retiro de fármaco contra Sida - Jun 9, 2007 Las autoridades del Minsa retiraron de las unidades de salud del paÃs el fármaco Viracept --también conocido como Nelfinavir--, tras descubrirse lotes de ... El Nuevo Diario Roche retirará droga antisida por impureza en quÃmicos - Jun 9, 2007 El fármaco contra el virus del sida Viracept (nelfinavir), de la compañÃa farmacéutica suiza Roche, se retirará del mercado costarricense como medida ... La Nación Costa Rica CCSS garantiza medicina contra sida - Jul 15, 2007 La Caja Costarricense de Seguro Social (CCSS) garantiza que sus farmacias cuentan con Nelfinavir, un medicamento antirretroviral para los enfermos de sida. ... La Nación Costa Rica 本港逾120 人æœ?用回收抗愛滋病藥 - Jun 7, 2007 ...瑞士羅æ°?è—¥å» å®£å¸ƒå›žæ”¶ä¸€ç¨®æŠ—æ„›æ»‹ç—…è—¥Viracept （ è—¥å??nelfinavir ） ， å› ç‚ºéƒ¨ä»½å?— 化å¸å“?污染， 有å?¯èƒ½è‡´ç™Œã€‚ 本港衛生署表示， 這藥00 年在港註冊， 屬醫生處方藥物， ... 香港電å?° - 香港電å?° Nelfinavir komt terug op de markt - Nov 8, 2007 Nelfinavir mag weer gebruikt worden. De schorsing van de registratie is ingetrokken. Dit betekent dat het middel weer geproduceerd kan worden en naar ... Hiv Vereniging Nederland :: Agência de NotÃcias da Aids :: - Apr 23, 2008 Mariângela Simão, informou também que a farmacêutica Roche vai conduzir uma pesquisa no Brasil com gestantes que utilizaram o Nelfinavir. ... Agência de NotÃcias da Aids Brand Names/Synonyms: Nelfinavir is also known by the following brand names and/or synonyms1UN; AG1346; NELFINAVIR MESYLATE AG1343; NFV; NLF; Nelfinavir; Nelfinavir Mesylate; Nelfinavir [Inn:Ban]; Viracept Drug Category: Nelfinavir is categorized under the following by the FDA: Anti-HIV Agents; HIV Protease Inhibitors; ATC:J05AE04 Dosage Forms: Tablets, Oral powder Absorption: Well absorbed Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-[2-hydroxy-3-(3-hydroxy-2-methyl-benzoyl)amino-4-phenylsulfanyl-butyl]-N-tert-butyl-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxamide |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |